![Martha Rook](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martha Rook
Geschäftsführer bei DELCATH SYSTEMS, INC.
Profil
Martha S.
Rook is currently the Chief Operating Officer at Delcath Systems, Inc. Prior to her current position, she held various roles including Secretary & Director at Alliance for Regenerative Medicine, VP, Head-Gene Editing & Novel Modalities at EMD Millipore Corp., Chief Technical Operations Officer at Sigilon Therapeutics, Inc., and Chief Technical Operations Officer at Insitro, Inc. Ms. Rook holds a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Texas A&M University.
Aktive Positionen von Martha Rook
Unternehmen | Position | Beginn |
---|---|---|
DELCATH SYSTEMS, INC. | Geschäftsführer | 18.03.2024 |
Ehemalige bekannte Positionen von Martha Rook
Unternehmen | Position | Ende |
---|---|---|
Insitro, Inc.
![]() Insitro, Inc. BiotechnologyHealth Technology Insitro, Inc. engages in engages in the discovery and development of drug products. Its approach include population scale data, cell-based disease models, biology at scale, cutting-edge machine learning, and predictive insights and new medicines. The company was founded by Daphne Koller and is headquartered in Portola Valley, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2024 |
SIGILON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.03.2022 |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Corporate Officer/Principal | 01.01.2018 |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Direktor/Vorstandsmitglied | - |
Ausbildung von Martha Rook
Texas A&M University | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SIGILON THERAPEUTICS, INC. | Health Technology |
DELCATH SYSTEMS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
EMD Millipore Corp.
![]() EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Insitro, Inc.
![]() Insitro, Inc. BiotechnologyHealth Technology Insitro, Inc. engages in engages in the discovery and development of drug products. Its approach include population scale data, cell-based disease models, biology at scale, cutting-edge machine learning, and predictive insights and new medicines. The company was founded by Daphne Koller and is headquartered in Portola Valley, CA. | Health Technology |